Glecaprevir + pibrentasvir (Maviret)

BNF:
Not listed
Status:
Red
Decision Date:
February 2018
 

Comments

RED1,2,3: NICE TA499: Treatment of chronic hepatitis C virus infections in adults. (Decision date - February 2018)

NHS England drug - to be used in line with NHS England commissioning intentions

Red Drug Classifications

  • 5: Is new to clinical practice and unfamiliar, necessitating a period of accumulation of experience, firstly (and most rapidly) by consultants/specialists

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app